Sign Out
ROZEVON is contraindicated: in patients with hypersensitivity to the active substances (rosuvastatin, ezetimibe) or to any of the excipients listed in Description.
In patients with active liver disease including unexplained, persistent elevations of serum transaminases.
During pregnancy and breast-feeding and in women of childbearing potential not using appropriate contraceptive measures.
In patients with severe renal impairment (creatinine clearance <30 ml/min).
In patients receiving concomitant ciclosporin.
Continue with Google